Products

Being one of the first to isolate primary hepatocytes and enterocytes in the industry, IVAL’s scientists continue to develop novel products for your ADMET research needs. Our high-quality primary cells are pre-screened and characterized for metabolic and transporter activities. Both viability and plate ability are optimized for your application. We stand by our products with first-class consultation and technical support service.

Hepatocytes

Enterocytes

MassBio Lunch and Learn IVAL Contract Research Service: In vitro screening for human-specific adverse drug properties Speaker: Albert P. Li, PhD, President and CEO of IVAL Clinical trial failure is a major challenge for drug development. Reasons for the failures are unexpected adverse drug properties that, due to species difference, ... Read More »

IVAL’s MetMax™ Technology Wins EPA’s Transform Tox Challenge IVAL’s MetMax™ system has been selected as one of the five winners in the Transform Toxicity Challenge by National Toxicology Program (NTP) and the United States Environmental Protection Agency (EPA). High-throughput screening (HTS) assays are deployed to rapidly test whether some of ... Read More »

IVAL is named as a semi-finalist in the "Transform Tox Testing Challenge" created to improve chemical screening. IVAL continues its series of innovative approaches to the comprehensive understanding of toxicity. The Transform Tox Testing Challenge was created by a coalition of Federal Agencies: the Environmental Protection Agency (EPA) and the ... Read More »

Connect With Us

Search By Keyword

Search for:

Products

Being one of the first to isolate primary hepatocytes and enterocytes in the industry, IVAL’s scientists continue to develop novel products for your ADMET research needs. Our high-quality primary cells are pre-screened and characterized for metabolic and transporter activities. Both viability and plate ability are optimized for your application. We stand by our products with first-class consultation and technical support service.